175 related articles for article (PubMed ID: 35750581)
21. Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7.
Marconi L; Bensalah K; Bex A;
Eur Urol; 2019 Jul; 76(1):e12-e13. PubMed ID: 30922689
[No Abstract] [Full Text] [Related]
22. Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.
Wu RC; Li DX; Feng DC
Eur Urol; 2024 Mar; 85(3):e87-e88. PubMed ID: 38151444
[No Abstract] [Full Text] [Related]
23. Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.
Zhao Z; Li Z; Yu N
Eur Urol; 2024 Mar; 85(3):e83-e84. PubMed ID: 38143217
[No Abstract] [Full Text] [Related]
24. Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
Mori K; Schmidinger M; Egawa S; Gust KM; Shariat SF
Eur Urol; 2021 Apr; 79(4):e113-e114. PubMed ID: 33487477
[No Abstract] [Full Text] [Related]
25. Re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034.
Patel HD; Allaf ME
Eur Urol; 2013 Nov; 64(5):e105-6. PubMed ID: 23910939
[No Abstract] [Full Text] [Related]
26. Re: Julia Dagnæs-Hansen, Gitte Hjartbro Kristensen, Hein V. Stroomberg, Søren Schwartz Sørensen, Martin Andreas Røder. Surgical Approaches and Outcomes in Living Donor Nephrectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.03.021.
Pecoraro A; Li Marzi V; Serni S; Campi R
Eur Urol Focus; 2023 Jan; 9(1):216-217. PubMed ID: 35798648
[No Abstract] [Full Text] [Related]
27. Reply to Lorenzo Marconi, Karim Bensalah, and Axel Bex's Letter to the Editor re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019;76:136-7.
Verhagen PCMS; Boevé ER
Eur Urol; 2019 Jul; 76(1):e14. PubMed ID: 30910344
[No Abstract] [Full Text] [Related]
28. Re: Nizar M. Tannir, Eric Jonasch, Laurence Albiges, et al. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN):A Randomized Multicenter Phase 2 Trial. Eur Urol 2016;69:866-74.
Yang Z; Qi L; Chen M
Eur Urol; 2017 Jan; 71(1):e23-e24. PubMed ID: 27344295
[No Abstract] [Full Text] [Related]
29. Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng's Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.
Eppler M; Ganjavi C; Abreu A; Gill I; Cacciamani GE
Eur Urol; 2024 Mar; 85(3):e85-e86. PubMed ID: 38182492
[No Abstract] [Full Text] [Related]
30. Re: Steven MacLennan, Eilidh Duncan, Ted A. Skolarus, et al. Improving Guideline Adherence in Urology. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.007.
Montorsi F
Eur Urol Focus; 2022 Nov; 8(6):1867. PubMed ID: 35153171
[No Abstract] [Full Text] [Related]
31. Reply to Hiten D. Patel and Mohamad E. Allaf's letter to the editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034.
Sun M; Karakiewicz PI; Trinh QD
Eur Urol; 2013 Nov; 64(5):e107-8. PubMed ID: 23910940
[No Abstract] [Full Text] [Related]
32. Re: Lazaros Tselves, Robert Geraghty, Riccardo Lombardo, et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.06.016.
Hsi RS; Hollingsworth JM; Koyama T
Eur Urol Focus; 2023 Mar; 9(2):383. PubMed ID: 36182575
[No Abstract] [Full Text] [Related]
33. Reply to Mengda Zhang and Long Wang's Letter to the Editor re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
Amparore D; Checcucci E; Fiori C; Porpiglia F
Eur Urol; 2020 Jun; 77(6):e163-e164. PubMed ID: 32279902
[No Abstract] [Full Text] [Related]
34. Re: Anders Lidgren, Ylva Hedberg, Kjell Grankvist, Torgny Rasmuson, Anders Bergh and Börje Ljungberg. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006;50:1272-7.
Minervini A; Di Cristofano C; Serni S; Carini M
Eur Urol; 2007 May; 51(5):1451-2; author reply 1452-3. PubMed ID: 17239525
[No Abstract] [Full Text] [Related]
35. Re: Andrea Gallioli, Angelo Territo, Romain Boissier, et al. Learning Curve in Robotic-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.008.
Yao J; Pleass HCC; Lau HMH
Eur Urol; 2020 Jun; 77(6):e165. PubMed ID: 32312545
[No Abstract] [Full Text] [Related]
36. Re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020.
Höglund M;
Eur Urol; 2023 Aug; 84(2):e50. PubMed ID: 37268487
[No Abstract] [Full Text] [Related]
37. Re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate.
Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M; Montironi R
Eur Urol; 2021 Sep; 80(3):e81-e82. PubMed ID: 34148712
[No Abstract] [Full Text] [Related]
38. Re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol. 2021;80:760-2: Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki.
Takahashi T
Eur Urol; 2022 Feb; 81(2):e44-e45. PubMed ID: 34887116
[No Abstract] [Full Text] [Related]
39. Reply to Ryan S. Hsi, John M. Hollingsworth, and Tatuki Koyama's Letter to the Editor re: Lazaros Tzelves, Robert Geraghty, Riccardo Lombardo, et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.06.016.
Tzelves L; Geraghty R; Lombardo R; Davis NF; Petřík A; Neisius A; Gambaro G; Türk C; Thomas K; Somani B; Skolarikos A
Eur Urol Focus; 2023 Mar; 9(2):381-382. PubMed ID: 36184536
[No Abstract] [Full Text] [Related]
40. Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
Montorsi F; Rosiello G; Gandaglia G
Eur Urol Oncol; 2024 Apr; 7(2):300. PubMed ID: 37838554
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
